KPI data tables
Clover Health operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.
| Period | Adjusted SG&A % of revenue |
|---|---|
| Q3 2026 | 15 |
| Q2 2026 | 15.1 |
| Q1 2026 | 15.9 |
| Q4 2025 | 20 |
| Q3 2025 | 14.3 |
| Q2 2025 | 17.3 |
| Q1 2025 | 18 |
| Q4 2024 | 25.5 |
| Q3 2024 | 18.7 |
| Q2 2024 | 20.1 |
| Q1 2024 | 21.6 |
Source: Clover Health Form 8-K Exhibit 99.1, Adjusted SG&A as a % of Total revenues. Q1 2024 21.6% and Q1 2025 18.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 20.1% and Q2 2025 17.3%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 18.7% and Q3 2025 14.3%: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 25.5% and Q4 2025 20.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 15.9%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 15.1%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 15.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.
| Period | Average MA members |
|---|---|
| Q3 2026 | 158,383 |
| Q2 2026 | 156,840 |
| Q1 2026 | 154,607 |
| Q4 2025 | 112,654 |
| Q3 2025 | 108,231 |
| Q2 2025 | 105,494 |
| Q1 2025 | 101,959 |
| Q4 2024 | 82,209 |
| Q3 2024 | 80,753 |
| Q2 2024 | 80,016 |
| Q1 2024 | 79,265 |
Source: Clover Health Form 8-K Exhibit 99.1, Average Medicare Advantage membership. Q1 2024 79,265 and Q1 2025 101,959: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 80,016 and Q2 2025 105,494: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 80,753 and Q3 2025 108,231: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 82,209 and Q4 2025 112,654: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 154,607: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 156,840: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 158,383: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.
| Period | Cash, cash equivalents, and investments |
|---|---|
| Q3 2026 | 512.6 |
| Q2 2026 | 443 |
| Q1 2026 | 418.2 |
| Q4 2025 | 319.9 |
| Q3 2025 | 395.9 |
| Q2 2025 | 389.3 |
| Q1 2025 | 390.8 |
| Q4 2024 | 437.6 |
| Q3 2024 | 531.4 |
| Q2 2024 | 482.8 |
| Q1 2024 | 440.3 |
Source: Clover Health Form 8-K Exhibit 99.1, Total cash, cash equivalents, and investments. Q1 2024 440.3 and Q1 2025 390.8: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 482.8 and Q2 2025 389.3: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 531.4 and Q3 2025 395.9: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 437.6 and Q4 2025 319.9: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 418.2: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 443.0: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 512.6: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.
| Period | Insurance BER |
|---|---|
| Q3 2026 | 91.1 |
| Q2 2026 | 87.6 |
| Q1 2026 | 86.5 |
| Q4 2025 | 95 |
| Q3 2025 | 93.5 |
| Q2 2025 | 88.4 |
| Q1 2025 | 86.1 |
| Q4 2024 | 82.8 |
| Q3 2024 | 82.8 |
| Q2 2024 | 76.1 |
| Q1 2024 | 83.2 |
Source: Clover Health Form 8-K Exhibit 99.1, Insurance Segment Insurance BER. Q1 2024 83.2% and Q1 2025 86.1%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 76.1% and Q2 2025 88.4%: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 82.8% and Q3 2025 93.5%: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 82.8% and Q4 2025 95.0%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 86.5%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 87.6%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 91.1%: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.
| Period | Insurance (Medicare Advantage) | Non-Insurance (DCE / ACO REACH) |
|---|---|---|
| FY 2025 | 113,803 | 0 |
| FY 2024 | 82,664 | 0 |
| FY 2023 | 81,205 | 50,529 |
| FY 2022 | 88,627 | 164,887 |
| FY 2021 | 68,120 | 61,876 |
Source: Clover Health Form 8-K Exhibit 99.1, Lives under Clover Management. FY 2021 Insurance 68,120 and DCE 61,876: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000011/a12312021-earningsrelease.htm. FY 2022 Insurance 88,627 and Non-Insurance 164,887, FY 2023 Insurance 81,205 and Non-Insurance 50,529: https://investors.cloverhealth.com/static-files/01a3ac32-054a-4723-80c7-b0721d7a3ea3. FY 2024 Insurance 82,664: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000049/aexx991xearningsreleasex4q.htm. FY 2025 Insurance 113,803: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm.
| Period | Period-end MA members |
|---|---|
| Q3 2026 | 158,907 |
| Q2 2026 | 157,309 |
| Q1 2026 | 155,773 |
| Q4 2025 | 113,803 |
| Q3 2025 | 109,226 |
| Q2 2025 | 106,323 |
| Q1 2025 | 103,418 |
| Q4 2024 | 82,664 |
| Q3 2024 | 81,110 |
| Q2 2024 | 80,261 |
| Q1 2024 | 79,527 |
Source: Clover Health Form 8-K Exhibit 99.1, Lives under Clover Management. Q1 2024 79,527 and Q1 2025 103,418: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000127/ax1q25exx991xearningsrelea.htm. Q2 2024 80,261 and Q2 2025 106,323: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/ax2q25exx991xearningsrelea.htm. Q3 2024 81,110 and Q3 2025 109,226: https://investors.cloverhealth.com/static-files/d2c89da5-1694-4007-90e4-432e93a3c07c. Q4 2024 82,664 and Q4 2025 113,803: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000050/ax4q25exx991xearningsrelea.htm. Q1 2026 155,773: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/a1q26exx991xearningsrelease.htm. Q2 2026 157,309: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/a2q26exx991xearningsrelease.htm. Q3 2026 158,907: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/a3q26exx991xearningsrelease.htm.